The New Order: Integrated Customer Organizations and Cancer Drug Management

Proximity Health’s research service delivers actionable insights through comprehensive primary research

1. Financial incentives are changing

• Anthem ties 58% of provider reimbursement to “value”
• CMS’ Oncology Care Model and MACRA redefine cancer providers’ business models

2. A set of critical new customers is emerging as oncology care consolidates

• IDNs owned 60% of oncology practices by late 2015
• Consolidation continues as changes reward economic scale and negotiating power

3. ICOs are building structures and processes to guide cancer drug selection

• ICOs implement restrictive formularies, guidelines, and pathways
• IT systems knit dispersed oncology networks together
• Internal Specialty Pharmacy operations leverage 340B pricing